Hisamitsu Pharmaceutical Co Inc (HTSUF)
24.56
0.00 (0.00%)
USD |
OTCM |
Jun 17, 16:00
Hisamitsu Pharmaceutical Total Liabilities (Quarterly): 409.58M for Feb. 29, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 409.58M |
| November 30, 2023 | 431.24M |
| August 31, 2023 | 473.58M |
| May 31, 2023 | 418.87M |
| February 28, 2023 | 407.13M |
| November 30, 2022 | 468.79M |
| August 31, 2022 | 444.12M |
| May 31, 2022 | 438.63M |
| February 28, 2022 | 415.09M |
| November 30, 2021 | 440.05M |
| August 31, 2021 | 446.09M |
| May 31, 2021 | 395.00M |
| February 28, 2021 | 432.01M |
| November 30, 2020 | 440.11M |
| August 31, 2020 | 436.21M |
| May 31, 2020 | 439.49M |
| February 29, 2020 | 524.16M |
| November 30, 2019 | 527.28M |
| August 31, 2019 | 488.36M |
| May 31, 2019 | 427.24M |
| February 28, 2019 | 425.33M |
| November 30, 2018 | 487.48M |
| August 31, 2018 | 493.35M |
| May 31, 2018 | 468.55M |
| February 28, 2018 | 508.88M |
| Date | Value |
|---|---|
| November 30, 2017 | 509.88M |
| August 31, 2017 | 493.23M |
| May 31, 2017 | 466.21M |
| February 28, 2017 | 439.97M |
| November 30, 2016 | 481.62M |
| August 31, 2016 | 526.22M |
| May 31, 2016 | 506.93M |
| February 29, 2016 | 517.40M |
| November 30, 2015 | 518.59M |
| August 31, 2015 | 522.99M |
| May 31, 2015 | 489.89M |
| February 28, 2015 | 530.89M |
| November 30, 2014 | 536.45M |
| August 31, 2014 | 620.48M |
| May 31, 2014 | 546.14M |
| February 28, 2014 | 543.86M |
| November 30, 2013 | 560.13M |
| August 31, 2013 | 595.79M |
| May 31, 2013 | 472.48M |
| February 28, 2013 | 500.45M |
| November 30, 2012 | 557.05M |
| August 31, 2012 | 609.17M |
| May 31, 2012 | 591.75M |
| February 29, 2012 | 541.23M |
| November 30, 2011 | 655.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
395.00M
Minimum
May 2021
527.28M
Maximum
Nov 2019
446.09M
Average
439.49M
Median
May 2020
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 51.76B |
| Nxera Pharma Co Ltd | 570.88M |
| PeptiDream Inc | 195.91M |
| Healios KK | 84.36M |
| AnGes Inc | 19.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.182B |
| Shareholders Equity (Quarterly) | 1.758B |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 4.224 |
| Net Debt Paydown Yield | 0.01% |